Background Secondary progressive multiple sclerosis (SPMS) is a subtype of multiple
sclerosis (MS), which is a chronic neurological disease, characterised by inflammation of the …

Recent interest in multiple sclerosis research warrants literature analysis to evaluate the
current state of the discipline and new research domains. This bibliometric review …

Background Late-onset multiple sclerosis (LOMS) is defined as the onset of symptoms
above 50 years, corresponding to an increasingly recognized subset of MS. This study …

Background Automated, technically simple analytical methods offering objective results are
highly valued in clinical laboratories. Kappa free light chains (KFLC) in cerebrospinal fluid …

Abstract Background The Brief Repeatable Battery of Neuropsychological Tests (BRBN-T) is
one of the most sensitive and used measures for detecting cognitive impairment in Multiple …

Background Up to 31% of patients with relapsing-remitting multiple sclerosis (RRMS)
discontinue treatment with disease-modifying drug (DMD) within the first year, and of the …

Multiple sclerosis (MS) is a chronic neurological disease with a global prevalence that has
risen over the past decade. The literature suggests that in comparison with a healthy control …

Multiple sclerosis (MS) is the most common chronic inflammatory, demyelinating, and
neurodegenerative disease of the central nervous system in young adults, representing the …

Introduction: Epidemiological data indicate that neurodegenerative diseases show a high
prevalence with a progressive increasing trend, especially in aging populations, as is the …

Introduction: Multiple sclerosis is a disease with a heterogeneous evolution. The early
identification of secondary progressive multiple sclerosis is a clinical challenge, which would …